LLYEli Lilly and CompanyRunning, no new patients
A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate Cancer
Prostate Cancer
0Calmworry score, out of 100
No strong warning signs right now. The score counts warning signs; it is not a prediction.
Why this score
No warning signs right now. That's why the score is 0.
Score over time
- Stage
- Phase 2/3
- Patients
- 393 (final count)
- Started
- Nov 26, 2018
- Main results expected
- Jan 2, 2024
- Fully finished
- Dec 2026
- Results posted
- Mar 6, 2025
What counts as success
The trial's main goal(s), called the “primary outcome.”
Radiographic Progression Free Survival (rPFS)
Measured over: From Date of Randomization to Radiographic Disease Progression or Death from Any Cause (Up to 60 Months)
Changes Tremor has spotted
No changes since Tremor started watching this trial.
Show details (technical version)
Score inputs
- none
Raw record changes
- none yet
Trial ID NCT03706365 · record last updated 2026-08-07 · checked 2026-11-09 15:36 UTC